Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
Biology
|
December 17, 2016
Critical Function of PRDM2 in the Neoplastic Growth of Testicular Germ Cell Tumors
Erika Di Zazzo, Carola Porcile, Silvia Bartollino, et al.
Annals of Medicine
|
May 27, 2021
Influence of gut microbiota on eye diseases: an overview
Pasquale Napolitano, Mariaelena Filippelli, Sergio Davinelli, et al.
British Journal of Clinical Pharmacology
|
October 14, 2017
Phenytoin: its potential as neuroprotective and retinoprotective drug
Flavia Chiosi, Jan Keppel Hesselink, Michele Rinaldi, et al.
Current Cancer Drug Targets
|
January 29, 2008
Looking at drug resistance mechanisms for microtubule interacting drugs: does TUBB3 work?
Cristiano Ferlini, Giuseppina Raspaglio, Lucia Cicchillitti, et al.
International Ophthalmology
|
December 4, 2019
Intraocular pressure reduction with once-a-day application of a new prostaglandin eye drop: a pilot placebo-controlled study in 12 patients
Ciro Caruso, Luigi Pacente, Pasquale Troiano, et al.
Pharmaceutics
|
July 12, 2020
A Novel Vitamin E TPGS-Based Formulation Enhances Chlorhexidine Bioavailability in Corneal Layers
Ciro Caruso, Amalia Porta, Alessandra Tosco, et al.
Current Pharmaceutical Design
|
November 15, 2019
Melatonin: Implications for Ocular Disease and Therapeutic Potential
Luca Scuderi, Sergio Davinelli, Clemente Maria Iodice, et al.
Frontiers in Pharmacology
|
October 16, 2019
Morphological and Functional Evaluation of Oral Citicoline Therapy in Chronic Open-Angle Glaucoma Patients: A Pilot Study With a 2-Year Follow-Up
Michele Lanza, Ugo Antonello Gironi Carnevale, Luigi Mele, et al.
International Ophthalmology
|
January 10, 2020
Effects of an antioxidant protective topical formulation on retinal tissue of UV-exposed rabbits
Silvia Bartollino, Marisa Palazzo, Francesco Semeraro, et al.
Expert Opinion on Drug Safety
|
July 17, 2019
Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an update
Ciro Costagliola, Francesco Morescalchi, Sarah Duse, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
Biology
|
December 17, 2016
Critical Function of PRDM2 in the Neoplastic Growth of Testicular Germ Cell Tumors
Erika Di Zazzo, Carola Porcile, Silvia Bartollino, et al.
Annals of Medicine
|
May 27, 2021
Influence of gut microbiota on eye diseases: an overview
Pasquale Napolitano, Mariaelena Filippelli, Sergio Davinelli, et al.
British Journal of Clinical Pharmacology
|
October 14, 2017
Phenytoin: its potential as neuroprotective and retinoprotective drug
Flavia Chiosi, Jan Keppel Hesselink, Michele Rinaldi, et al.
Current Cancer Drug Targets
|
January 29, 2008
Looking at drug resistance mechanisms for microtubule interacting drugs: does TUBB3 work?
Cristiano Ferlini, Giuseppina Raspaglio, Lucia Cicchillitti, et al.
International Ophthalmology
|
December 4, 2019
Intraocular pressure reduction with once-a-day application of a new prostaglandin eye drop: a pilot placebo-controlled study in 12 patients
Ciro Caruso, Luigi Pacente, Pasquale Troiano, et al.
Pharmaceutics
|
July 12, 2020
A Novel Vitamin E TPGS-Based Formulation Enhances Chlorhexidine Bioavailability in Corneal Layers
Ciro Caruso, Amalia Porta, Alessandra Tosco, et al.
Current Pharmaceutical Design
|
November 15, 2019
Melatonin: Implications for Ocular Disease and Therapeutic Potential
Luca Scuderi, Sergio Davinelli, Clemente Maria Iodice, et al.
Frontiers in Pharmacology
|
October 16, 2019
Morphological and Functional Evaluation of Oral Citicoline Therapy in Chronic Open-Angle Glaucoma Patients: A Pilot Study With a 2-Year Follow-Up
Michele Lanza, Ugo Antonello Gironi Carnevale, Luigi Mele, et al.
International Ophthalmology
|
January 10, 2020
Effects of an antioxidant protective topical formulation on retinal tissue of UV-exposed rabbits
Silvia Bartollino, Marisa Palazzo, Francesco Semeraro, et al.
Expert Opinion on Drug Safety
|
July 17, 2019
Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an update
Ciro Costagliola, Francesco Morescalchi, Sarah Duse, et al.
Page
of 4